Milky Way Biotech

The day has finally come 💫. We moved in the laboratory for the first time at DTU Skylab to perform our in-vitro study. This is one big step towards the development of gene therapy for lactose intolerance. 🔬

On this mission we are having on board two wonderful DTU students with lots of experience and dedication to acquire proof of concept data. 📚

Lucía Mompó Gisbert and Elisa Terenzi in collaboration with our science team members (Penille Jensen, Ioanna Chini, Angeliki Panetsou, Mario Alzamora, Patrik Szoboszlai) making enormous efforts in starting up our HEK-293 cell culture. We are all super excited to progress in the lab and make the cell culture produce Lactase enzyme as the main objective. 🚀

We are going to update you regularly on the progress of our in-vitro study, so stay tuned. Thank you for the support for DTU Skylab, Jacob Martin Nielsen, Meat Tomorrow, and Thermo Fisher Scientific. 🙌

One pipette set closer to the 1st in-vitro studies. 🚀🥳 As we are getting ready to move into the GMO laboratory at DTU Skylab, materials, consumables, and equipment are starting to arrive.

It feels like Christmas receiving every single item, but this baby "Finnpipette™ F2 GLP-KIT" from Thermo Fisher Scientific is obviously the star of the show and can not wait taking it into use. 💫

Most of our in-vitro associated items are coming from Thermo Fisher Scientific as a part of the Jump Start Biotech program with significant discounts. Thank you for supporting our mission. 🙌

Warm welcome to Johannes Conforti to the Milky Way Team. 🤝

Johannes got aligned to our project as a fund raiser along a special course we offer at DTU, 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐒𝐭𝐚𝐫𝐭-𝐔𝐩 𝐒𝐨𝐟𝐭 𝐅𝐮𝐧𝐝𝐢𝐧𝐠. Along the course he is having a pivotal role in learning and optimizing fund raising strategy, and handling fund applications for Milky Way. 🚀

Johannes is learning MSc Technology Entrepreneurship at DTU - Technical University of Denmark and holding experience in entrepreneurship, and fund raising as Co-Founder of Custom Pair. 📚

It was a pleasure having Elizabeth Robinson on board with us along the 1st Special Course we ever offered at DTU - Technical University of Denmark.

Our special course "𝐌𝐚𝐩𝐩𝐢𝐧𝐠 𝐨𝐮𝐭 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐩𝐥𝐚𝐧 𝐟𝐨𝐫 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲" was focused on the foundational knowledge, understanding that is necessary to navigate in the complex regulatory landscape of gene therapies. 🗺🧬

The output of the special course is a detailed step by step regulatory plan custom made for Milky Way Biotech ApS by Elizabeth, which is soon going to become a crucial element of our ambitious journey. 🚀

We couldn`t have wished for a better person, and student to take this course with us. Thank you Elizabeth for all your efforts, and hands down for the high quality work you delivered. 🎉

If you are interested in taking a course or thesis with us at DTU, comment below this post, or reach out to [email protected]. 👋

What a great workshop we just attended, facilitated by our partner Thermo Fisher Scientific. Leaving the seats with hands full of learnings, and new considerations for our 1st in-vitro studies in relation to AAVs and GeneArt services. We are grateful for having such a meaningful collaboration established alongside the Jump Start Biotech Program. 🔬

Special thanks for your efforts organizing and facilitating the work shop Camilla Niklasson, PhD, Umme Hany Islam, and Ian Pringle. 🙌

🎄🌟 𝐌𝐞𝐫𝐫𝐲 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐟𝐫𝐨𝐦 𝐌𝐢𝐥𝐤𝐲 𝐖𝐚𝐲 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐀𝐩𝐒! 🌟🎄

As the year comes to an end, we would like to express our gratitude to our dedicated mentors, collaborators, followers, and everyone that supported us throughout 2023. Your support and guidance have been key components of our progress and achievements. 🎅

Almost a year ago, in January 2023, the idea of Milky Way Biotech was born, taking on an important mission and ambitious journey with developing somatic gene therapy treatment for lactose intolerance.

Since then, we have come a long way, and are currently preparing to go into the laboratory to perform in-vitro studies to acquire proof of concept. It wouldn’t have been possible without our wonderful team, and you.

We are wishing you a peaceful and joyous holiday season filled with warmth and cheer. As we look forward to 2024, we remain committed to our mission and excited about the new opportunities and challenges it will bring. Your continued support and engagement will be invaluable as we navigate this journey together. 🦌

Technical University of Denmark, DTU Skylab, Mikrolegat, BioInnovation Institute, Københavns Universitet - University of Copenhagen, Thermo Fisher Scientific.

It is time to start with the Nordic Life Science Days 2023 and present about our mission and progress at Milky Way Biotech along the Nordic Stars Pitches. 💫 Excited to meet many of you along the event and get into some interesting conversation. 🫱🏽‍🫲🏻

Yesterday was a remarkable day for us at Milky Way Biotech as we participated in DTU Startup Day 2023. It was an event filled with inspiration, learning, and meaningful connections. 🤝

A big thank you to everyone we met at the event. Your interest, questions, and insights have added immense value to our endeavor. We're more motivated than ever to push the boundaries of biotech innovation. 🚀

Stay tuned for more updates as we embark on this thrilling phase of our journey. Let's revolutionize the way we approach lactose intolerance together!

Had a great time representing our start-up along the 𝐑𝐞𝐚𝐜𝐡 & 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 event organized by SBE DTU at Technical University of Denmark. 💫

This event aimed for students to get in touch with different research groups within life science and biotechnology and get an insight in their latest research and projects. 🚀

As an outcome, we managed connect to with a great number of students and raised awareness about our special courses which we are going to offer at DTU next year.
📚 BIOINFORMATICS: Modelling of Gene Therapy (5 ECTS)
📚 REGULATORY GUIDELINES: Mapping out Regulatory plan for Gene Therapy (5 ECTS)

Meanwhile in November we are looking forward to attending the following events:
• DTU Start-up Talks: 15th of November (17.30 - 20:00) at DTU Skylab
• DTU Start-up Day: 16th November (09:00 - 16:30) at DTU Skylab
• Nordic LifeScience Day: 29th and 30th November (08:00 - 18:00) at Bella Center Copenhagen

Book your calendars and come and connect with us. 🫱🏽‍🫲🏻

Exciting news! Our startup, 𝐌𝐢𝐥𝐤𝐲 𝐖𝐚𝐲 𝐁𝐢𝐨𝐭𝐞𝐜𝐡, 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐚𝐝𝐦𝐢𝐭𝐭𝐞𝐝 𝐭𝐨 𝐭𝐡𝐞 𝐩𝐫𝐞𝐬𝐭𝐢𝐠𝐢𝐨𝐮𝐬 𝐍𝐨𝐫𝐝𝐢𝐜 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐚𝐲 2023 (NLS) event. 🚀

The NLS event is a remarkable congregation of innovators and thought leaders in the life science industry. This year, it celebrates its 10th anniversary, showcasing a decade of fostering a community dedicated to life sciences. The event is set to take place in the beautiful city of Copenhagen, Denmark, for the first time, at the Bella Arena-Bella Center on 29-30 November 2023​. 💫

The NLS is the largest Nordic partnering conference dedicated to the life science industry, nurturing a unique space for business, innovation, and networking. We are thrilled to represent Milky Way Biotech at the NLS 2023 and look forward to the engaging discussions, learnings, and partnerships that lie ahead. The journey towards making a notable difference in the lives of those with lactose intolerance continues, and we are grateful for the recognition and opportunities that come with being part of such a reputable event. 🫱🏽‍🫲🏻

Feel free to connect with us during the event. Let’s explore how we can collaborate to drive innovation in the biotech realm🙌 https://www.nlsdays.com/

Come and meet us in person in Copenhagen along the DTU Startup Day 2023 on 16-Nov-2023 / 09:00 - 16:30 at DTU Skylab. 🚀

DTU - Technical University of Denmark brings together the next generation of tech entrepreneurs and businesses to showcase the vibrant startup scene on and around its campus. Investors and industry representatives are invited to interact with over 60 early-stage, knowledge-based startups. These startups will not only display their innovative prototypes and technologies in the exhibition but also pitch their business concepts on stage. 📚

Make sure to sign up in time to secure your sport. You can sign up by using the following link: https://lnkd.in/ea3TtSHT. We are looking forward to meeting you there. 🫶

🥛Did You Know?🍪
While most people associate lactose with milk and dairy products, it's also hidden in many unexpected places! From bread and processed meats to candies, chocolates, and even some medications, lactose can be lurking where you least expect it. For those with lactose intolerance, this means constant vigilance and uncertainty when choosing foods and beverages.

At Milky Way Biotech, we're pioneering a somatic gene therapy for lactose intolerance, aiming to bring certainty and comfort back to the dining table. Imagine a world where you don't have to second-guess every bite or sip. We're working to make that dream a reality! 🚀
Join us on our journey to redefine the future of food freedom.

A new week of learning at Milky Way Biotech, three of our Science team members got accredited with the FELASA (A,D) license at Aarhus University. Now all of our Science members are accredited! 🎓

With this license, they'll be able to carry experiments in our Pre-Clinical Studies starting early next year. Getting us a step closer to permanently curing lactose intolerance! 🔬

𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰 that lactose intolerance affects over 90% of the population in countries like China, South Korea, and Thailand? In the United States, up to 25% of the population may be affected, while in Latin America, the numbers can soar up to 70%. Even in Northern Europe, known for its dairy-rich traditions, up to 15% of people can't enjoy dairy without discomfort. 🥛🚫

At Milky Way Biotech ApS, we're pioneering a groundbreaking gene therapy treatment to address this global concern. Our mission? To make dairy delightful for everyone, everywhere. From Asia to the Americas to Europe, we're on a quest to redefine dairy consumption. Stay tuned for more updates on our innovative journey! 🧬

The 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 came to an end, leaving us with 𝐩𝐥𝐞𝐧𝐭𝐲 𝐨𝐟 𝐥𝐞𝐚𝐫𝐧𝐢𝐧𝐠𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐩𝐢𝐫𝐚𝐭𝐢𝐨𝐧 which we are going to use to improve our pitching, and business strategy. We are grateful for Eurotech Universities Alliance💫, and for everyone that made this possible. 🚀

The 1st part of the program took place at TUM Technische Universität München, meeting other bright minds from start-ups with impactful missions based in Eindhoven University of Technology, DTU Skylab, École polytechnique, and EPFL (École Polytechnique Fédérale de Lausanne). Along the time we spent in Munich, we learnt about important considerations for pitching from Alan Armstrong, customer interviews from Lisa Schebitz, and intercultural interactions from Katharina Kratzer. Meanwhile we managed to explore the beautiful city of Munich, biting on the authentic German pretzel. 🥨

The 2nd destination of the program was at DTU - Technical University of Denmark in Copenhagen, attending workshops focused on B2B sales from Jakob Svagin and Anne Gladbo Platz, insights into business angels mindset from Jan Rosenbom, inclusion from Ingrid Haug, and stake holder management from Jens Friholm.💡

Our co-founders Angeliki Panetsou, Mario Alzamora, and Patrik Szoboszlai are going to make sure that the learnings are going to be utilized for the benefits of our Mission.

𝐓𝐡𝐞 𝐅𝐢𝐫𝐬𝐭 “𝐌𝐢𝐥𝐤𝐲” 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝🥛💫

In the past 4 months plenty of effort went into AAV plasmid engineering, and the dedication, brightness, and consistent work delivered by our science team members finally pays off: The first version of our AAV plasmid construct (our gene delivery machinery) designed to treat genetic lactose intolerance is ready for implementation. 🧬

Even though there is a big pool of milestones to be achieved along the way till we can bring our treatment to market 💊, having our 1st AAV (Adeno Associated Virus) plasmid construct feels like a big step toward the realization of our common mission “improving the health and well being of millions of lactose intolerant individuals”.

This achievement enable us to accelerate toward the in-vitro studies🔬 which by we are going to test the efficiency, and safety of the AAV plasmid construct on cell cultures mimicking the properties of human cells located in the epithelial brush layer of the small intestine.

Shout out to our dedicated Science Team members involved in the AAV engineering activities. 🙌🏽 Angeliki Panetsou, and Mario Alzamora.

Introducing André Gil Castro👨‍💻, Chief Information Officer and Web Development Specialist.

🚀 Meet André Gil Castro, our Chief Information Officer at Milky Way Biotech. With expertise in web development and IT administration, André brings a unique set of skills to our team. Originally from Peru and raised in Sweden, André recently completed his master's thesis in Sustainable Energy Utilization as part of the Environmental Engineering program at the KTH Royal Institute of Technology.

As a web developer, André creates captivating websites, including the website for Rebilance, a Danish food supplement start-up. His eye for design ensures visually appealing online user experiences.

🌟 Team Update Alert! 🌟

We're stoked to announce that Petteri Heljo has joined Milky Way Biotech as a mentor!

Petteri is a wizard 🧙‍♂️ in the world of oral drug discovery and biophysics, he's got some serious superpowers. With 15+ years in pharma, Petteri has been recently leading Oral Drug Product Research at Novo Nordisk, and will soon embark on a new role focusing more broadly on early-stage drug development.

His experience in leading oral biologic formulation research will be pivotal in ensuring our lactose intolerance gene therapy navigates safely through the gastric acids and into the gut, where it can interact with the target cells.

We're thrilled to have Petteri on our team and can't wait to make strides in the fight against lactose intolerance with him. Welcome to the family, Petteri! 🎉

🌟Meet the Team: Introducing Mario Alzamora👨‍🔬, Biotechnologist and Entrepreneur🌟

🚀 Meet Mario Alzamora, our Spanish-Swedish Biotechnologist, and Entrepreneur, currently completing a double Masters in Biotechnology at DTU - Technical University of Denmark and Manufacturing at Massachusetts Institute of Technology, with five years of valuable experience in the pharmaceutical industry at Novo Nordisk.

At Milky Way Biotech, Mario is responsible for the scientific team and his innovative idea for a gene therapy to tackle lactose intolerance set the foundation for the company.

Simultaneously, Mario has previous experience in the Entrepreneurial world, acting as CEO of Rebilance, a Danish food supplement startup. And he is also the President for the Society for Biological Engineering (SBE DTU) at DTU Bioengineering.

Mario's multi-faceted expertise, proactive attitude, and unrelenting commitment to give value make him a vital asset to our team.

Stay tuned for more team introductions!

𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰 𝐭𝐡𝐚𝐭 𝐥𝐚𝐜𝐭𝐨𝐬𝐞 𝐢𝐧𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞 𝐜𝐚𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩 𝐚𝐭 𝐚𝐧𝐲 𝐚𝐠𝐞? 🤔
Let's discover together the 4 reasons that are responsible for this!
---------------------------------------------------------------------------
1. 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐋𝐚𝐜𝐭𝐨𝐬𝐞 𝐈𝐧𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞: The most common type of lactose intolerance. It occurs when the body produces insufficient amounts of lactase, the enzyme responsible for breaking down lactose. Primary lactose intolerance is typically an inherited condition and is more prevalent in certain ethnic groups, such as individuals of African, Asian, Hispanic, or Native American descent.

2. 𝐒𝐞𝐜𝐨𝐧𝐝𝐚𝐫𝐲 𝐋𝐚𝐜𝐭𝐨𝐬𝐞 𝐈𝐧𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞: Occurs as a result of an underlying condition or injury that damages the lining of the small intestine, where lactase is produced. Common causes of secondary lactose intolerance include gastrointestinal infections, celiac disease, Crohn's disease, and chemotherapy.

3. 𝐂𝐨𝐧𝐠𝐞𝐧𝐢𝐭𝐚𝐥 𝐋𝐚𝐜𝐭𝐨𝐬𝐞 𝐈𝐧𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞: This is a rare, genetic form of lactose intolerance that is present from birth. Babies with congenital lactose intolerance are unable to produce any lactase and cannot tolerate breast milk or standard infant formulas that contain lactose.

4. 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐀𝐝𝐮𝐥𝐭 𝐋𝐚𝐜𝐭𝐨𝐬𝐞 𝐌𝐚𝐥𝐚𝐛𝐬𝐨𝐫𝐩𝐭𝐢𝐨𝐧: In some cases, individuals may experience lactose malabsorption without exhibiting typical symptoms of lactose intolerance. While lactose is not fully digested, it is still absorbed to some extent by the body. This condition is often referred to as primary adult lactose malabsorption.
---------------------------------------------------------------------------
Join us on our journey to make lactose intolerance a thing of the past! 🚀🥛

🚀 Milky Way Biotech at the 17th BioPharma Nexus Conference! 🚀

Two of our key team members, Mario Alzamora and Penille Jensen, represented Milky Way Biotech at the prestigious 17th BioPharma Nexus Conference in Amsterdam this week.

This dynamic platform provided our team with an invaluable opportunity to delve deeper into advancements and innovative solutions in clinical trials, including planning, management, and operations.

We will use this broader understanding of the clinical trial landscape, aligning with our mission to develop an innovative genetic therapy for lactose intolerance.

The connections and insights gathered at this conference will propel our research and development efforts forward, and we're excited to bring these learnings back to our team and continue working towards a future where lactose intolerance is a thing of the past.

We want to give a warm welcome to Penille Jensen 🎉, Preclinical Research Scientist and Immunologist. 👩‍🔬🇩🇰

Penille Jensen is a PhD student at Københavns Universitet - University of Copenhagen The Pipeline, UCPH within laboratory animal science research, and she will take the role of dedicated Lead Preclinical Research Scientist at Milky Way Biotech. 🔬

Penille is deeply committed to upholding the highest standards in conducting in vivo studies. At Milky Way Biotech, she will assume responsibility for leading the preclinical research team. With Penille's scientific resilience and exceptional management skills, she will ensure the highest quality in all pilot and preclinical studies conducted at Milky Way Biotech.

🎉Level of optimism is on its peak at Milky Way Biotech, and there is a good reason for that: 𝐏𝐫𝐨𝐮𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐚𝐭 𝐰𝐞 𝐞𝐬𝐭𝐚𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐚 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐰𝐢𝐭𝐡 𝐓𝐡𝐞𝐫𝐦𝐨 𝐅𝐢𝐬𝐡𝐞𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜, 𝐛𝐞𝐢𝐧𝐠 𝐚𝐝𝐦𝐢𝐭𝐭𝐞𝐝 𝐭𝐨 𝐭𝐡𝐞 𝐉𝐮𝐦𝐩 𝐒𝐭𝐚𝐫𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 𝐟𝐨𝐫 𝐁𝐢𝐨𝐭𝐞𝐜𝐡.

Thermo Fisher Scientific Inc. is an American, world leader supplier of scientific instrumentation, reagents and consumables, and software services with a mission to enable the customers to make the world healthier, cleaner and safer, commited to corporate social responsibility and sustainable growth. 📈

The Jump Start Program for Biotech is an exclusive new lab partnership program designed specifically to help us achieve our research and commercialization goals through out support with flexible finance plans for instruments, guidance with regulatory and compliance affairs, unique product discounts, and consultation on scientific technical application to just mention a few. 🚀 🔬

We are confident that this partnership is going to accelerate our progress with the development of our somatic gene therapy treatment for lactose intolerance, and making a positive impact on the health and well being of millions of people.

Shout out to Camilla Niklasson, PhD (Account Manager at Thermo Fisher Scientific, Denmark), and Aamar Sadiq (Senior Inside Sales Account Manager at Thermo Fisher Scientific) for making this possible. 🙌

We're happy to announce that Milky Way Biotech secured two spots to participate in the European Venture Program taking place in Munich at The Entrepreneurial University (TUM), and in Copenhagen at DTU in the beginning of August 2023! 🚀🇩🇪🇩🇰

Our candidates for attending the program are Angeliki Panetsou and Patrik Szoboszlai, who are going to make sure that the learnings are going to be implemented, taking our business strategy and venture network to the next level.📖 🤝

Along the program, we are going to participate in thematic workshops in venture creation, receiving peer feedback and networking opportunities with local start-ups, companies, governmental and public organisations, technology experts, business coaches, VCs and more.

EuroTech Universities Alliance, Technical University of Munich, DTU - Technical University of Denmark

🌟Meet our new team member: Introducing Divya Dasagrandhi👩‍🔬, Preclinical Research Scientist, Molecular Biologist, and Biochemist🌟

🚀 Meet our Preclinical Research Scientist, coming from India 🇮🇳. Divya holds a Ph.D. in Biochemistry (Molecular Cardiology) from Bharathidasan University, and was collecting experience as Teaching Assistant, Academic Consultant, Postdoctoral Researcher, and now as a Research Consultant at Københavns Professionshøjskole.

We are confident that Divya is an excellent addition to the team, bringing her knowledge and experience in preclinical research, analytical thinking, and positive mindset. Looking forward to sharing our journey with her, and becoming an essential contributor to our research activities. 🔬

🌟We would like to give a warm welcome to our new Mentor, Kamilla Rolsted 👩 Entrepreneur, Business Developer, currently working as the Chief Business Officer at Pephexia Therapeutics ApS🌟

🚀 With 10+ years of experience in the field of health care innovation and business development, we are looking forward to her guidance and expertise as we bring our innovative lactose intolerance therapy to market.

🌟 Meet the Team: Introducing 𝘼𝙣𝙜𝙚𝙡𝙞𝙠𝙞 𝙋𝙖𝙣𝙚𝙩𝙨𝙤𝙪🌟
----------------------------------------------------
🎓 Background: Molecular Biology & Genetics
🔎 Research interest: Human Gut Microbiome
🌍 Dream vacation: Japan, Latin America
----------------------------------------------------
📔 A quote that could change the world:
“𝘌𝘷𝘦𝘳𝘺𝘰𝘯𝘦 𝘪𝘴 𝘧𝘪𝘨𝘩𝘵𝘪𝘯𝘨 𝘢 𝘣𝘢𝘵𝘵𝘭𝘦 𝘵𝘩𝘢𝘵 𝘺𝘰𝘶 𝘬𝘯𝘰𝘸 𝘯𝘰𝘵𝘩𝘪𝘯𝘨 𝘢𝘣𝘰𝘶𝘵. 𝘉𝘦 𝘬𝘪𝘯𝘥”

𝐓𝐡𝐞 𝐇𝐢𝐝𝐝𝐞𝐧 𝐂𝐨𝐬𝐭 𝐨𝐟 𝐋𝐚𝐜𝐭𝐨𝐬𝐞 𝐢𝐧𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞💰

We often focus on the physical discomfort and dietary limitations of lactose intolerance. But have you considered its economic implications? 💰

For example, 𝐥𝐚𝐜𝐭𝐨𝐬𝐞-𝐟𝐫𝐞𝐞 𝐦𝐢𝐥𝐤 can be up to double the price of regular milk in some countries. A liter of lactose free milk per week could add up to around $100 more to your annual grocery bill.

Over-the-counter 𝐥𝐚𝐜𝐭𝐚𝐬𝐞 𝐬𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 can cost about $10-20 per month, totaling $120-240 per year.

Frequent 𝐝𝐨𝐜𝐭𝐨𝐫 𝐯𝐢𝐬𝐢𝐭𝐬 𝐨𝐫 𝐭𝐞𝐬𝐭𝐬 to manage symptoms often add hundreds of dollars to annual healthcare expenses. And 𝐈𝐧𝐝𝐢𝐫𝐞𝐜𝐭 𝐜𝐨𝐬𝐭𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬 𝐦𝐢𝐬𝐬𝐞𝐝 𝐰𝐨𝐫𝐤 due to discomfort aren't as easy to quantify but also contribute to the financial burden.

By addressing lactose intolerance at its genetic root, we aim to eliminate the need for expensive alternatives and help individuals lead a more carefree life.

Join us on our journey to make lactose intolerance a thing of the past! 🚀🥛

🌟Meet the Team: Introducing Patrik Szoboszlai 👨, COO and Co-Founder 🌟

🚀 Meet Patrik Szoboszlai, our Hungarian COO and Co-Founder, now based in Denmark for the past 5 years. As the heart of our operations and business team, his leadership is instrumental in our mission.

🎓Background: Biotechnology Engineer
👨‍🔬Experience: Novo Nordisk A/S
🤗A funny story: "At Danish BMX race the speaker called me as “Leverpostej” because he could not pronounce my family name…"
🍜Favourite food: Vietnamese Pho soup
🎬Favourite movies: IT 1 and 2 remake, American Pie
🎸Favourite music genres: New Metal, Metal, Punk Rock
🎼Favourite bands: Linkin Park, Breaking Benjamin, Falling in Reverse
🌎The dream vacation: Italy, Hawaii, China, Japan, Vietnam

Stay tuned for more team introductions!